Schmidt AW - Search Results

1

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Seeger TF, Seymour PA, Schmidt AW, Zorn SH, Schulz DW, Lebel LA, McLean S, Guanowsky V, Howard HR, Lowe JA 3rd, et al. Seeger TF, et al. Among authors: schmidt aw. J Pharmacol Exp Ther. 1995 Oct;275(1):101-13. J Pharmacol Exp Ther. 1995. PMID: 7562537

2

Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo.

Kleiman RJ, Chapin DS, Christoffersen C, Freeman J, Fonseca KR, Geoghegan KF, Grimwood S, Guanowsky V, Hajós M, Harms JF, Helal CJ, Hoffmann WE, Kocan GP, Majchrzak MJ, McGinnis D, McLean S, Menniti FS, Nelson F, Roof R, Schmidt AW, Seymour PA, Stephenson DT, Tingley FD, Vanase-Frawley M, Verhoest PR, Schmidt CJ. Kleiman RJ, et al. Among authors: schmidt cj, schmidt aw. J Pharmacol Exp Ther. 2012 May;341(2):396-409. doi: 10.1124/jpet.111.191353. Epub 2012 Feb 10. J Pharmacol Exp Ther. 2012. PMID: 22328573

3

The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review.

Seymour PA, Schmidt AW, Schulz DW. Seymour PA, et al. Among authors: schmidt aw. CNS Drug Rev. 2003 Spring;9(1):57-96. doi: 10.1111/j.1527-3458.2003.tb00244.x. CNS Drug Rev. 2003. PMID: 12595912 Free PMC article. Review.

4

The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels.

Schmidt AW, McLean S, Heym J. Schmidt AW, et al. Eur J Pharmacol. 1992 Sep 4;219(3):491-2. doi: 10.1016/0014-2999(92)90498-s. Eur J Pharmacol. 1992. PMID: 1385177

5

1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents.

Lowe JA 3rd, Seeger TF, Nagel AA, Howard HR, Seymour PA, Heym JH, Ewing FE, Newman ME, Schmidt AW, Furman JS, et al. Lowe JA 3rd, et al. Among authors: schmidt aw. J Med Chem. 1991 Jun;34(6):1860-6. doi: 10.1021/jm00110a016. J Med Chem. 1991. PMID: 1676427

6

3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.

Howard HR, Lowe JA 3rd, Seeger TF, Seymour PA, Zorn SH, Maloney PR, Ewing FE, Newman ME, Schmidt AW, Furman JS, Robinson GL, Jackson E, Johnson C, Morrone J. Howard HR, et al. Among authors: schmidt aw. J Med Chem. 1996 Jan 5;39(1):143-8. doi: 10.1021/jm950625l. J Med Chem. 1996. PMID: 8568801

7

Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor.

McLean S, Ganong A, Seymour PA, Bryce DK, Crawford RT, Morrone J, Reynolds LS, Schmidt AW, Zorn S, Watson J, Fossa A, DePasquale M, Rosen T, Nagahisa A, Tsuchiya M, Heym J. McLean S, et al. Among authors: schmidt aw. J Pharmacol Exp Ther. 1996 May;277(2):900-8. J Pharmacol Exp Ther. 1996. PMID: 8627572

8

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.

Rollema H, Lu Y, Schmidt AW, Zorn SH. Rollema H, et al. Among authors: schmidt aw. Eur J Pharmacol. 1997 Nov 5;338(2):R3-5. doi: 10.1016/s0014-2999(97)81951-6. Eur J Pharmacol. 1997. PMID: 9456005

9

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.

Rollema H, Lu Y, Schmidt AW, Sprouse JS, Zorn SH. Rollema H, et al. Among authors: schmidt aw. Biol Psychiatry. 2000 Aug 1;48(3):229-37. doi: 10.1016/s0006-3223(00)00850-7. Biol Psychiatry. 2000. PMID: 10924666

10

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.

Schmidt AW, Lebel LA, Howard HR Jr, Zorn SH. Schmidt AW, et al. Eur J Pharmacol. 2001 Aug 17;425(3):197-201. doi: 10.1016/s0014-2999(01)01188-8. Eur J Pharmacol. 2001. PMID: 11513838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters